Skip to main content

Market Overview

Morning Market Gainers

Share:

Oragenics Inc (NYSE: OGEN) shares surged 43.68 percent to $2.50 after the company reported positive data for multiple compounds from its Mutacin 1140 lantibiotic platform.

Cytec Industries Inc (NYSE: CYT) shares climbed 26.22 percent to $73.71 after Belgium's Solvay announced its plans to buy Cytec for $5.5 billion.

Strayer Education Inc (NASDAQ: STRA) jumped 20.26 percent to $50.22 after the company reported stronger-than-expected Q2 results.

Natural Health Trends Corp. (NASDAQ: NHTC) surged 20.27 percent to $29.73 after the company reported Q2 results and lifted its dividend by 33 percent to $0.04 per share. The company's board authorized a $15 million share repurchase.

The Rubicon Project Inc (NYSE: RUBI) gained 15.39 percent to $17.77 on upbeat Q2 results.

Calix Inc (NYSE: CALX) shares rose 14.29 percent to $8.00 after the company reported better-than-expected Q2 results.

Buffalo Wild Wings (NASDAQ: BWLD) surged 11.47 percent to $190.92 after the company reported its quarterly financial results.

Citrix Systems, Inc. (NASDAQ: CTXS) shares jumped 6.04 percent to $73.83 after the company reported upbeat Q2 earnings and announced that Chief Executive Mark Templeton will retire.

Gilead Sciences, Inc. (NASDAQ: GILD) shares gained 4.77 percent to $118.46 as the company reported better-than-expected earnings for the second quarter and raised its FY15 sales forecast.

 

Related Articles (CYT + OGEN)

View Comments and Join the Discussion!

Posted-In: Market GainersNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com